Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Biomed Chromatogr ; 35(1): e4874, 2021 Jan.
Article in English | MEDLINE | ID: mdl-32367587

ABSTRACT

Venlafaxine (VFX) is a serotonin and norepinephrine reuptake inhibitor chiral drug used in therapy as an antidepressant in the form of a racemate consisting of R- and S-VFX. The two enantiomers of VFX exhibit different pharmacological activities: R-VFX inhibits both norepinephrine and serotonin synaptic reuptake, whereas S-VFX inhibits only the serotonin one. R- and S-VFX are metabolized in the liver to the respective R- and S-O-desmethylvenlafaxine (ODVFX), R- and S-N-desmethylvenlafaxine (NDVFX), and R- and S-N,O-didesmethylvenlafaxine (NODVFX). The pharmacological profile of ODVFX is close to that of VFX, whereas the other two chiral metabolites (NDVFX and NODVFX) have lower affinity for the receptor sites. The pharmacokinetics of the VFX enantiomers appear stereoselective, including the metabolism process. In the past 20 years, several studies describing the enantioselective analysis of R- and S-VFX in pharmaceutical formulations and its chiral metabolites in biological matrices were published. These methods encompass liquid chromatography coupled with UV detection, mass spectrometry, or tandem mass spectrometry, and capillary electrophoresis. This paper reviews the published methods used for the determination of the individual enantiomers of VFX and its chiral metabolites in different matrices.


Subject(s)
Desvenlafaxine Succinate , Venlafaxine Hydrochloride , Antidepressive Agents , Chromatography, Liquid , Cyclohexanols/analysis , Cyclohexanols/chemistry , Cyclohexanols/isolation & purification , Cyclohexanols/pharmacokinetics , Desvenlafaxine Succinate/analysis , Desvenlafaxine Succinate/chemistry , Desvenlafaxine Succinate/isolation & purification , Desvenlafaxine Succinate/pharmacokinetics , Electrophoresis, Capillary , Humans , Stereoisomerism , Tandem Mass Spectrometry , Venlafaxine Hydrochloride/analysis , Venlafaxine Hydrochloride/chemistry , Venlafaxine Hydrochloride/isolation & purification , Venlafaxine Hydrochloride/pharmacokinetics
2.
PLoS One ; 15(9): e0238954, 2020.
Article in English | MEDLINE | ID: mdl-32941505

ABSTRACT

Desvenlafaxine (DES) and Alprazolam (ALP) are the drugs commonly prescribed together for the treatment of Major Depressive Disorders (MDD). A literature survey revealed, there is no method for the simultaneous determination of these two drugs. The purpose of this research was to develop and validate a simple, accurate, precise, robust, and isocratic RP-HPLC method for simultaneous determination of DES and ALP in human spiked plasma using UV-detector in short analysis time. The method utilized Hypersil BDS C18 (250 mm×4.6 mm, 5 µm) through an isocratic mode of elution using HPLC grade acetonitrile and 0.02M KH2PO4 buffer (65:35) and 0.1% Tri Fluoro Acetic acid (TFA) with pH 4.00 adjusted with 1M KOH. The flow rate was 1.00 mLmin-1 and elution of the drugs was monitored at 230nm. The elution time of DES and ALP was 4.011 and 5.182 minutes respectively. The method was linear for the concentration range 10-150 µgmL-1 for DES and 5.0-75.0 µgmL-1 for ALP. According to the validation results, the method is sensitive with Limit of Detection (LOD) 4.740 µgmL-1 and Limit of Quantification (LOQ) of 14.365 µgmL-1 for DES and LOD 1.891 µgmL-1 & LOQ 5.730 µgmL-1 for ALP. The reproducibility of results with minute deliberate variations in method parameters has proven that the method is robust. The data from stability studies show a non-significant change in drugs solutions for 2 months. The optimized method was validated as per International Conference for Harmonisation (ICH) Q2(R1) guidelines. This method can be used for the estimation of DES and ALP in plasma and can evaluate pharmacokinetic parameters of both drugs simultaneously.


Subject(s)
Alprazolam/isolation & purification , Chromatography, High Pressure Liquid/methods , Desvenlafaxine Succinate/isolation & purification , Alprazolam/analysis , Alprazolam/blood , Desvenlafaxine Succinate/analysis , Desvenlafaxine Succinate/blood , Humans , Limit of Detection , Pharmaceutical Solutions , Plasma/chemistry , Reproducibility of Results
3.
Anal Bioanal Chem ; 408(16): 4247-56, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27108286

ABSTRACT

A hollow fiber solid-phase microextraction method for pre-concentration of venlafaxine and o-desmethylvenlafaxine in biological matrices is described for the first time. The functionalized MWCNTs with an amino acid, glycine, were synthesized and held in the pore of a hollow fiber by sol-gel technique. In order to extract venlafaxine and o-desmethylvenlafaxine from real samples, the hollow fiber was immersed into the sample solution under a magnetic stirring for 20 min. The extracted venlafaxine and o-desmethylvenlafaxine from the fibers were then desorbed with methanol by sonication and analyzed using high-performance liquid chromatography. Important microextraction parameters including pH of donor phase, donor phase volume, stirring rate, extraction time, and desorption conditions such as the type and volume of solvents and desorption time were thoroughly investigated and optimized. The optimized technique provides good repeatability (RSD of the intraday precision 3.7 and 3.4, interday precision of 5.8 and 5.4 %), linearity of (0.1-300 and 0.2-360 ng mL(-1)), low LODs of (0.03 and 0.07 ng mL(-1)), and high enrichment factor of (164 and 176) for venlafaxine and o-desmethylvenlafaxine, respectively. The analytical performance of Gly-MWCNTs as a new SPME sorbent was compared with MWCNTs and carboxylic MWCNTs. The results indicate that Gly-MWCNTs are quite effective for extraction of venlafaxine and o-desmethylvenlafaxine. Feasibility of the method was evaluated by analyzing human urine and real water samples. The results obtained in this work show a promising, simple, selective, and sensitive sample preparation and determination method for biological and water samples.


Subject(s)
Antidepressive Agents/isolation & purification , Desvenlafaxine Succinate/isolation & purification , Glycine/chemistry , Nanotubes, Carbon/chemistry , Solid Phase Microextraction/methods , Urine/chemistry , Venlafaxine Hydrochloride/isolation & purification , Water Pollutants, Chemical/isolation & purification , Adsorption , Antidepressive Agents/analysis , Antidepressive Agents/urine , Chromatography, High Pressure Liquid , Desvenlafaxine Succinate/analysis , Desvenlafaxine Succinate/urine , Humans , Limit of Detection , Rivers/chemistry , Solid Phase Microextraction/instrumentation , Venlafaxine Hydrochloride/analysis , Venlafaxine Hydrochloride/urine , Water Pollutants, Chemical/analysis , Water Pollutants, Chemical/urine
4.
J Chromatogr A ; 1420: 119-28, 2015 Nov 13.
Article in English | MEDLINE | ID: mdl-26460073

ABSTRACT

To-date, there has been no effective chiral capillary electrophoresis-mass spectrometry (CE-MS) method reported for the simultaneous enantioseparation of the antidepressant drug, venlafaxine (VX) and its structurally-similar major metabolite, O-desmethylvenlafaxine (O-DVX). This is mainly due to the difficulty of identifying MS compatible chiral selector, which could provide both high enantioselectivity and sensitive MS detection. In this work, poly-sodium N-undecenoyl-L,L-leucylalaninate (poly-L,L-SULA) was employed as a chiral selector after screening several dipeptide polymeric chiral surfactants. Baseline separation of both O-DVX and VX enantiomers was achieved in 15 min after optimizing the buffer pH, poly-L,L-SULA concentration, nebulizer pressure and separation voltage. Calibration curves in spiked plasma (recoveries higher than 80%) were linear over the concentration range 150-5000 ng/mL for both VX and O-DVX. The limit of detection (LOD) was found to be as low as 30 ng/mL and 21 ng/mL for O-DVX and VX, respectively. This method was successfully applied to measure the plasma concentrations of human volunteers receiving VX or O-DVX orally when co-administered without and with indinivar therapy. The results suggest that micellar electrokinetic chromatography electrospray ionization-tandem mass spectrometry (MEKC-ESI-MS/MS) is an effective low cost alternative technique for the pharmacokinetics and pharmacodynamics studies of both O-DVX and VX enantiomers. The technique has potential to identify drug-drug interaction involving VX and O-DVX enantiomers while administering indinivar therapy.


Subject(s)
Chromatography, Micellar Electrokinetic Capillary/methods , Desvenlafaxine Succinate/isolation & purification , HIV Infections/blood , Spectrometry, Mass, Electrospray Ionization/methods , Tandem Mass Spectrometry/methods , Venlafaxine Hydrochloride/isolation & purification , Calibration , Desvenlafaxine Succinate/blood , Drug Interactions , Electrophoresis, Capillary/methods , HIV/physiology , HIV Infections/drug therapy , HIV Protease Inhibitors/therapeutic use , Humans , Indinavir/therapeutic use , Limit of Detection , Polymers/chemistry , Stereoisomerism , Venlafaxine Hydrochloride/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...